Catalyst Wire Dossier Catalyst Wire Dossier

Imipenem and Cilastatin

Imipenem and Cilastatin Sodium · Fresenius Kabi USA, LLC
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Imipenem and Cilastatin, covering 2015-04-15 to 2024-04-04. Get the full timeline:

Most recent: FDA Approved: IMIPENEM AND CILASTATIN — Supplemental Application (WG Critical Care, LLC)

See pricing